Sign in
AZTR Stock Price, Chart, Stats & News
Azitra, Inc.
Save
Azitra, Inc. (AZTR) does not currently pay a dividend.
1.80M
Market cap
–
Current P/E
–
Forward P/E
AZTR chart
About
Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases. The company's pipeline features several key therapeutic candidates: ATR-12: A genetically modified strain of S. epidermidis intended to treat Netherton syndrome, a specific skin disorder.
Similar securities
Based on sector and market capitalization
Report issue